GlassScriptPhysician profile
Michelle Leal
NPI 1093185894
$462.12
in general payments reported to CMS, 2019-2025
12 companies · $220 in 2025
The $220 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $37.56 · 2022: $54.43 · 2023: $88.30 · 2024: $61.61 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $147.41 | 2025 | Affinity, Apligraf, Puraply Wound Matrix |
| Lilly USA, LLC | $108.42 | 2022-2024 | Mounjaro, Trulicity |
| Novo Nordisk INC | $38.63 | 2022-2024 | Ozempic, Rybelsus |
| Radius Health, INC. | $29.88 | 2021 | |
| Abbvie INC. | $26.52 | 2023 | |
| Exact Sciences Corporation | $20.64 | 2025 | Cologuard Collection Kit |
| Urgo Medical North America, LLC | $18.05 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Paratek Pharmaceuticals, INC. | $18.02 | 2025 | Nuzyra |
| Phadia US INC. | $16.19 | 2023 | Immunocap |
| Otsuka America Pharmaceutical, INC. | $16.10 | 2025 | Rexulti |
| Pfizer INC. | $14.58 | 2023 | |
| Genentech USA, INC. | $7.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Leal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.